BlackRock’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,971,873
Closed -$19.6M 5588
2025
Q1
$19.6M Sell
3,971,873
-250,781
-6% -$797K ﹤0.01% 2952
2024
Q4
$12.4M Buy
4,222,654
+352,558
+9% +$1.45M ﹤0.01% 3309
2024
Q3
$18.3M Buy
3,870,096
+209,073
+6% +$943K ﹤0.01% 3096
2024
Q2
$14.1M Sell
3,661,023
-244,382
-6% -$1.1M ﹤0.01% 3184
2024
Q1
$20.9M Sell
3,905,405
-6,319
-0.2% -$29.7K ﹤0.01% 2970
2023
Q4
$16.7M Sell
3,911,724
-504,085
-11% -$1.55M ﹤0.01% 3110
2023
Q3
$17.3M Buy
4,415,809
+280,625
+7% +$1.84M ﹤0.01% 3020
2023
Q2
$41.8M Buy
4,135,184
+974,661
+31% +$10.3M ﹤0.01% 2596
2023
Q1
$32.2M Buy
3,160,523
+153,911
+5% +$1.76M ﹤0.01% 2714
2022
Q4
$28.2M Buy
3,006,612
+424,476
+16% +$5.99M ﹤0.01% 2843
2022
Q3
$37.6M Buy
2,582,136
+53,200
+2% +$790K ﹤0.01% 2666
2022
Q2
$33.4M Buy
2,528,936
+935,172
+59% +$12.7M ﹤0.01% 2768
2022
Q1
$27.2M Sell
1,593,764
-8,919
-0.6% -$151K ﹤0.01% 2975
2021
Q4
$41.1M Buy
+1,602,683
New +$50M ﹤0.01% 2787

Other funds holding TSVT

BlackRock's TSVT Position: Q2 2025 in Review

BlackRock sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 3,971,873 shares — an estimated $19.6M sold.

BlackRock first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $41.8M in Q2 2023. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • BlackRock reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • BlackRock sold 3,971,873 2seventy bio shares in Q2 2025, an estimated $19.6M.
  • BlackRock first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • BlackRock's 2seventy bio position peaked at $41.8M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on BlackRock's 13F filing for Q2 2025, filed 12 Aug 2025.